で公開中です! 詳しく見る
AFJKのアイコン

Aimei Health Technology Co

12.27 USD
終値時点 更新済み 10月16日 16:00 EDT
1日
5日間
-1.84%
1か月
0.99%
3か月
2.25%
6か月
-74.44%
年初来
-83.83%
1年
7.63%
5年間
20.89%
10年間
20.89%
 

概要: Aimei Health Technology Co Ltd is a blank check company.

従業員数: 2

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 0%
ニュートラル 0%
ネガティブ 0%
ニュートラル
GlobeNewsWire
3 か月前
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
ニュートラル
GlobeNewsWire
4 か月前
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company's delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Quarterly Report was due on May 15, 2026.
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
ニュートラル
GlobeNewsWire
5 か月前
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
New York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company's delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Annual Report was due on March 31, 2026, and the Company filed a Notification of Late Filing on Form 12b-25 with the SEC on April 1, 2026.
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
ニュートラル
InvestorPlace
2 年前
AFJK Stock: 5 Things to Know as a United Hydrogen SPAC Merger Takes Shape
Aimei Health Technology (NASDAQ: AFJK ) stock is surprisingly down today despite news that the blank-check company will merge with United Hydrogen Group in a special purpose acquisition company (SPAC) merger worth roughly $1.6 billion. Indeed, United Hydrogen will go public on the Nasdaq through a very fashionable SPAC merger with Aimei, with a new ticker to boot.
AFJK Stock: 5 Things to Know as a United Hydrogen SPAC Merger Takes Shape
ポジティブ
Reuters
2 年前
China's United Hydrogen to list on Nasdaq via $1.6 bln blank-check deal
Green energy company United Hydrogen Group said on Thursday it would be listing its shares on the Nasdaq via a blank-check merger that values the company at $1.6 billion.
China's United Hydrogen to list on Nasdaq via $1.6 bln blank-check deal
価格チャートは Lightweight Charts™ を使用して実装されています